CD3xCD20 bispecific T-cell redirectors for relapsed or refractory B-cell lymphoma

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1109-1110
Number of pages2
JournalThe Lancet
Volume398
Issue number10306
DOIs
StatePublished - Sep 25 2021

Cite this